Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

151

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

Tags:

Previous Article

Broadly neutralizing antibodies against emerging delta-coronaviruses

Immunotherapy for glioblastoma and its microenvironment

Related Posts

Repurposing payloads: next generation of antibody–drug conjugates

Repurposing payloads: next generation of antibody–drug ...

52

Acutely blocking excessive mitochondrial fission prevents chronic neurodegeneration after traumatic brain injury

Acutely blocking excessive mitochondrial fission preven...

85

Thymic health consequences in adults

Thymic health consequences in adults

50